Merck interferon-free combination shows high hepatitis C cure rate in early study
Need for expansion of hepatitis C screening among veterans, 'baby-boom' generation and pregnant women highlighted
AbbVie’s two-drug, interferon-free combination cures genotype 1b hepatitis C infection in 95%
High response rates with telaprevir triple therapy for HIV-positive men with acute hepatitis C
In ELECTRON trial, 100% of hard-to-treat patients cured with sofosbuvir/ledipasvir plus ribavirin or GS-9669
Urgent need to improve sexually transmitted infection screening for MSM in Europe
Gay men who don't have anal sex still at high risk of bacterial STIs
Once-daily raltegravir effective as maintenance therapy
HIV rebound linked to higher baseline level, slower suppression and low-level viraemia
